Down syndrome gene dosage imbalance on cerebellum development
- 30 June 2007
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 82 (2) , 87-94
- https://doi.org/10.1016/j.pneurobio.2007.02.006
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21Nature, 2006
- Hedgehog AntagonistRENKCTD11Regulates Proliferation and Apoptosis of Developing Granule Cell ProgenitorsJournal of Neuroscience, 2005
- The Transcription Factor NFAT3 Mediates Neuronal SurvivalJournal of Biological Chemistry, 2005
- Chromosome 21 and Down syndrome: from genomics to pathophysiologyNature Reviews Genetics, 2004
- Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndromeHuman Molecular Genetics, 2004
- BACE-2 is overexpressed in Down’s syndromeExperimental Neurology, 2003
- Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndromeHuman Molecular Genetics, 2001
- Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouseHuman Molecular Genetics, 2000
- Structural and Functional Characteristics of Dyrk, a Novel Subfamily of Protein Kinases with Dual SpecificityProgress in Nucleic Acid Research and Molecular Biology, 1998
- Cerebellar Volume in Adults With Down SyndromeArchives of Neurology, 1997